In vivo assessment of the effect of taxifolin glycoside on atopic dermatitis-like skin lesions using biomedical tools in NC/Nga mice

J. Y. Kim, O. S. Lee, S. Ha, J. H. Kim, G. Park, J. K. Kim, Chil Hwan Oh

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background Noninvasive methods of assessment are widely used in clinical trials. However, such methods have not been established in atopic dermatitis (AD), which is a chronic inflammatory skin disease. Aim To demonstrate, using biomedical tools, the benefits of a new substance, taxifolin glycoside (TAX), in an AD model, the NC/Nga mouse. Methods We evaluated the efficacy of topical TAX for AD by measuring clinical skin severity score, cytokine expression and serum IgE level, and by using biomedical measures (vapometry and corneometry). Topical TAX was applied to AD-induced NC/Nga mice for 3 weeks. The anti-inflammatory effects of this compound were demonstrated noninvasively using biomedical tools and immunological assays. Results Our method of AD assessment using biomedical tools is more objective and accurate than visual inspection. The results obtained using the biomedical tools were identical to those obtained using immunological assays. Conclusions In vivo biomedical tools are useful for diagnosing and monitoring treatment effects in AD.

Original languageEnglish
Pages (from-to)547-555
Number of pages9
JournalClinical and Experimental Dermatology
Volume40
Issue number5
DOIs
Publication statusPublished - 2015 Jul 1

Fingerprint

Atopic Dermatitis
Glycosides
Skin
Skin Diseases
Immunoglobulin E
taxifolin
Anti-Inflammatory Agents
Clinical Trials
Cytokines
Serum

ASJC Scopus subject areas

  • Dermatology

Cite this

In vivo assessment of the effect of taxifolin glycoside on atopic dermatitis-like skin lesions using biomedical tools in NC/Nga mice. / Kim, J. Y.; Lee, O. S.; Ha, S.; Kim, J. H.; Park, G.; Kim, J. K.; Oh, Chil Hwan.

In: Clinical and Experimental Dermatology, Vol. 40, No. 5, 01.07.2015, p. 547-555.

Research output: Contribution to journalArticle

Kim, J. Y. ; Lee, O. S. ; Ha, S. ; Kim, J. H. ; Park, G. ; Kim, J. K. ; Oh, Chil Hwan. / In vivo assessment of the effect of taxifolin glycoside on atopic dermatitis-like skin lesions using biomedical tools in NC/Nga mice. In: Clinical and Experimental Dermatology. 2015 ; Vol. 40, No. 5. pp. 547-555.
@article{5d12d4d08e6040ce93a0700cfb0fb417,
title = "In vivo assessment of the effect of taxifolin glycoside on atopic dermatitis-like skin lesions using biomedical tools in NC/Nga mice",
abstract = "Background Noninvasive methods of assessment are widely used in clinical trials. However, such methods have not been established in atopic dermatitis (AD), which is a chronic inflammatory skin disease. Aim To demonstrate, using biomedical tools, the benefits of a new substance, taxifolin glycoside (TAX), in an AD model, the NC/Nga mouse. Methods We evaluated the efficacy of topical TAX for AD by measuring clinical skin severity score, cytokine expression and serum IgE level, and by using biomedical measures (vapometry and corneometry). Topical TAX was applied to AD-induced NC/Nga mice for 3 weeks. The anti-inflammatory effects of this compound were demonstrated noninvasively using biomedical tools and immunological assays. Results Our method of AD assessment using biomedical tools is more objective and accurate than visual inspection. The results obtained using the biomedical tools were identical to those obtained using immunological assays. Conclusions In vivo biomedical tools are useful for diagnosing and monitoring treatment effects in AD.",
author = "Kim, {J. Y.} and Lee, {O. S.} and S. Ha and Kim, {J. H.} and G. Park and Kim, {J. K.} and Oh, {Chil Hwan}",
year = "2015",
month = "7",
day = "1",
doi = "10.1111/ced.12522",
language = "English",
volume = "40",
pages = "547--555",
journal = "Clinical and Experimental Dermatology",
issn = "0307-6938",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - In vivo assessment of the effect of taxifolin glycoside on atopic dermatitis-like skin lesions using biomedical tools in NC/Nga mice

AU - Kim, J. Y.

AU - Lee, O. S.

AU - Ha, S.

AU - Kim, J. H.

AU - Park, G.

AU - Kim, J. K.

AU - Oh, Chil Hwan

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Background Noninvasive methods of assessment are widely used in clinical trials. However, such methods have not been established in atopic dermatitis (AD), which is a chronic inflammatory skin disease. Aim To demonstrate, using biomedical tools, the benefits of a new substance, taxifolin glycoside (TAX), in an AD model, the NC/Nga mouse. Methods We evaluated the efficacy of topical TAX for AD by measuring clinical skin severity score, cytokine expression and serum IgE level, and by using biomedical measures (vapometry and corneometry). Topical TAX was applied to AD-induced NC/Nga mice for 3 weeks. The anti-inflammatory effects of this compound were demonstrated noninvasively using biomedical tools and immunological assays. Results Our method of AD assessment using biomedical tools is more objective and accurate than visual inspection. The results obtained using the biomedical tools were identical to those obtained using immunological assays. Conclusions In vivo biomedical tools are useful for diagnosing and monitoring treatment effects in AD.

AB - Background Noninvasive methods of assessment are widely used in clinical trials. However, such methods have not been established in atopic dermatitis (AD), which is a chronic inflammatory skin disease. Aim To demonstrate, using biomedical tools, the benefits of a new substance, taxifolin glycoside (TAX), in an AD model, the NC/Nga mouse. Methods We evaluated the efficacy of topical TAX for AD by measuring clinical skin severity score, cytokine expression and serum IgE level, and by using biomedical measures (vapometry and corneometry). Topical TAX was applied to AD-induced NC/Nga mice for 3 weeks. The anti-inflammatory effects of this compound were demonstrated noninvasively using biomedical tools and immunological assays. Results Our method of AD assessment using biomedical tools is more objective and accurate than visual inspection. The results obtained using the biomedical tools were identical to those obtained using immunological assays. Conclusions In vivo biomedical tools are useful for diagnosing and monitoring treatment effects in AD.

UR - http://www.scopus.com/inward/record.url?scp=84931957771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931957771&partnerID=8YFLogxK

U2 - 10.1111/ced.12522

DO - 10.1111/ced.12522

M3 - Article

C2 - 25475067

AN - SCOPUS:84931957771

VL - 40

SP - 547

EP - 555

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

SN - 0307-6938

IS - 5

ER -